Buying ‘Political Intelligence’ Can Pay Off Big for Wall Street

January 18, 2013 by  
Filed under FX News

Marwood Group provides investors with insights on likely federal government actions; one call—saying an Amylin Pharmaceuticals diabetes drug faced headwinds at the FDA—has drawn the SEC’s attention.

WSJ.com: Markets

Print Friendly
Share in top social networks!

Comments are closed.